- Home
- ARDX vs RC Comparison
ARDX vs RC Comparison
Compare ARDX & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- RC
- Stock Information
- Founded
- ARDX 2007
- RC 2007
- Country
- ARDX United States
- RC United States
- Employees
- ARDX N/A
- RC N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- RC Real Estate Investment Trusts
- Sector
- ARDX Health Care
- RC Real Estate
- Exchange
- ARDX Nasdaq
- RC Nasdaq
- Market Cap
- ARDX 885.2M
- RC 755.3M
- IPO Year
- ARDX 2014
- RC N/A
- Fundamental
- Price
- ARDX $3.93
- RC $4.58
- Analyst Decision
- ARDX Strong Buy
- RC Hold
- Analyst Count
- ARDX 9
- RC 7
- Target Price
- ARDX $10.17
- RC $7.46
- AVG Volume (30 Days)
- ARDX 4.6M
- RC 1.7M
- Earning Date
- ARDX 07-31-2025
- RC 08-06-2025
- Dividend Yield
- ARDX N/A
- RC 10.87%
- EPS Growth
- ARDX N/A
- RC N/A
- EPS
- ARDX N/A
- RC N/A
- Revenue
- ARDX $361,706,000.00
- RC N/A
- Revenue This Year
- ARDX $12.01
- RC N/A
- Revenue Next Year
- ARDX $34.66
- RC $33.07
- P/E Ratio
- ARDX N/A
- RC N/A
- Revenue Growth
- ARDX 127.33
- RC N/A
- 52 Week Low
- ARDX $3.21
- RC $3.93
- 52 Week High
- ARDX $8.06
- RC $9.54
- Technical
- Relative Strength Index (RSI)
- ARDX 57.99
- RC 55.68
- Support Level
- ARDX $3.49
- RC $4.32
- Resistance Level
- ARDX $3.72
- RC $4.63
- Average True Range (ATR)
- ARDX 0.16
- RC 0.15
- MACD
- ARDX 0.06
- RC 0.01
- Stochastic Oscillator
- ARDX 98.21
- RC 72.60
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.